Hélène Eltchaninoff

TAVI at 20: how a crazy idea led to a clinical revolution

May 15, 2022 | 10.4244/EIJ-E-22-00007

Quantitative aortography assessment of aortic regurgitation

Modolo R, Chang C, Onuma Y, Schultz C, Tateishi H, Abdelghani M, Miyazaki Y, Aben J, Rutten M, Pighi M, El Bouziani A, van Mourik M, Lemos P, Wykrzykowska J, Brito F, Sahyoun C, Piazza N, Eltchaninoff H, Soliman O, Abdel-Wahab M, Van Mieghem N, de Winter R, Serruys P

October 9, 2020 | 10.4244/EIJ-D-19-00879

TAVI and valve performance: update on definitions, durability, transcatheter heart valve failure modes and management

Eltchaninoff H, Durand E, Barbanti M, Abdel-Wahab M

September 7, 2018 | 10.4244/EIJ-D-18-00653

TAVI durability beyond five years: no alarms, but stay alert

Eltchaninoff H, Durand E, Cribier A

July 20, 2018 | 10.4244/EIJV14I4A67

Matched comparison of next- and early-generation balloon-expandable transcatheter heart valve implantations in failed surgical aortic bioprostheses

Seiffert M, Treede H, Schofer J, Linke A, Wöhrle J, Baumbach H, Mehilli J, Bapat V, Simonato M, Walther T, Kullmer M, Boekstegers P, Ensminger S, Kurz T, Eltchaninoff H, Rastan A, Werner N, de Weger A, Frerker C, Lauer B, Mueller O, Whisenant B, Thukkani A, Weisz G, Dvir D

July 20, 2018 | 10.4244/EIJ-D-17-00546

Assessment of structural valve deterioration of transcatheter aortic bioprosthetic balloon-expandable valves using the new European consensus definition

Eltchaninoff H, Durand E, Avinee G, Tron C, Litzler P-Y, Bauer F, Dacher J-N, Werhlin C, Bouhzam N, Bettinger N, Candolfi P, Cribier A

June 14, 2018 | 10.4244/EIJ-D-18-00015

Long-term clinical outcomes after bioresorbable and permanent polymer drug-eluting stent implantation: final five-year results of the CENTURY II randomised clinical trial

Wijns W, Valdés Chávarri M, Richardt G, Moreno R, Iñiguez A, Barbato E, Carrié D, Ando K, Merkely B, Kornowski R, Eltchaninoff H, Stojkovic S, Saito S

June 14, 2018 | 10.4244/EIJ-D-18-00358

Five-year haemodynamic outcomes of the first-generation SAPIEN balloon-expandable transcatheter heart valve

Sawaya F, Kappetein AP, Wisser W, Nataf P, Thomas M, Schächinger V, De Bruyne B, Eltchaninoff H, Thielmann M, Himbert D, Romano M, Wimmer-Greinecker G, Serruys P, Lefèvre T

August 20, 2016

Will PARTNER change my practice? Placement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A trial – transcatheter or surgical aortic-valve replacement in intermediate-risk patients

Natarajan D, Makkar R, MacCarthy P, Eltchaninoff H, Søndergaard L, Prendergast B

August 20, 2016 | 10.4244/EIJV12I6A131

The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation: 12-month clinical outcomes

Gilard M, Schlüter M, Snow T, Dall’Ara G, Eltchaninoff H, Moat N, Goicolea J, Ussia G, Kala P, Wenaweser P, Zembala M, Nickenig G, Price S, Barrero E, Iung B, Zamorano P, Schuler G, Corti R, Alfieri O, Prendergast B, Ludman P, Windecker S, Sabaté M, Witkowski A, Danenberg H, Schroeder E, Romeo F, Macaya C, Derumeaux G, Laroche C, Pighi M, Serdoz R, Di Mario C

May 16, 2016 | 10.4244/EIJV12I1A15

Impact of chronic kidney disease on the outcomes of transcatheter aortic valve implantation: results from the FRANCE 2 registry

Oguri A, Yamamoto M, Mouillet G, Gilard M, Laskar M, Eltchaninoff H, Fajadet J, Iung B, Donzeau-Gouge P, Leprince P, Leguerrier A, Prat A, Lievre M, Chevreul K, Dubois-Randé J-L, Teiger E

January 22, 2015 | 10.4244/EIJV10I9A183

Impact of low preprocedural transvalvular gradient on cardiovascular mortality following TAVI: an analysis from the FRANCE 2 registry

Amabile N, Agostini H, Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Laskar M, Caussin C

November 20, 2014 | 10.4244/EIJV10I7A144

Patient selection for TAVI in 2014: is it justified to treat low- or intermediate-risk patients? The cardiologist’s view

Cribier A, Durand E, Eltchaninoff H

September 27, 2014 | 10.4244/EIJV10SUA3

The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients

Di Mario C, Eltchaninoff H, Moat N, Goicolea J, Ussia G, Kala P, Wenaweser P, Zembala M, Nickenig G, Barrero E, Snow T, Iung B, Zamorano P, Schuler G, Corti R, Alfieri O, Prendergast B, Ludman P, Windecker S, Sabaté M, Gilard M, Witkowski A, Danenberg H, Schröder E, Romeo F, Macaya C, Derumeaux G, Maggioni A, Tavazzi L

April 19, 2013 | 10.4244/EIJV8I12A209

Early and long-term results of unprotected left main coronary artery stenosis with paclitaxel-eluting stents: the FRIEND (French multicentre registry for stenting of unprotected LMCA stenosis) registry

Carrié D, Eltchaninoff H, Lefèvre T, Silvestri M, Brunel P, Fajadet J, Moynagh A, Gilard M, Koning R, Dibie A, Darremont O, Lablanche J, Blanchard D

October 28, 2011 | 10.4244/EIJV7I6A110

Aorto-iliac angiography as a screening tool in selecting patients for transfemoral aortic valve implantation with the Edwards SAPIEN bioprosthesis

Eltchaninoff H, Kerkeni M, Zajarias A, Tron C, Godin M, Sanchez Giron C, Baala B, Cribier A

September 30, 2009

Twelve month clinical and angiographic outcome after stenting of unprotected left main coronary artery stenosis with paclitaxel-eluting stents – results of the multicentre FRIEND registry

Carrié D, Eltchaninoff H, Lefèvre T, Silvestri M, Levy G, Maupas E, Brunel P, Fajadet J, Le Breton H, Gilard M, Blanchard D, Glatt B

January 20, 2009

Five month study of percutaneous heart valves in the systemic circulation of sheep using a novel model of aortic insufficiency

Eltchaninoff H, Nusimovici-Avadis D, Babaliaros V, Spenser B, Felsen B, Cribier A

February 20, 2006

Hélène Eltchaninoff

Latest news